tradingkey.logo
搜索

cbdMD Inc

YCBD
添加自选
0.685USD
+0.000+0.03%
收盘 07/02, 13:00美东报价延迟15分钟
7.19M总市值
0.02市盈率 TTM

cbdMD Inc

0.685
+0.000+0.03%
查看详细走势图
TradingKey 图表
盘中分时
1分
30分
1小时
日k
周k
月k
日k

今天

+0.03%

5天

-1.45%

1月

-8.67%

6月

-40.95%

今年开始到现在

-49.26%

1年

-20.35%

关键数据
0.680今开
0.685最高
72.42K成交量
0.02市盈率 TTM
亏损市盈率动
--股息TTM
0.69%换手率
0.680昨收
0.670最低
33.20K成交额
亏损市盈率静
0.77市净率
0.00%股息率 TTM
-22.91%ROA
2.56052周最高
0.76量比
-7.70M净利润
10.50M总股本
28.1293每股收益TTM
2.15Beta
-62.55%ROE
0.47052周最低
2.21%振幅
53.29%毛利率
7.19M总市值
-1.07回报/风险
8.73%风险率

TradingKey cbdMD Inc股票评分

单位: USD 更新时间: 2026-07-02

操作建议

cbdMD Inc当前公司基本面数据相对健康,增长潜力很大。当前估值合理,在药品行业排名105/157位。机构持股占比非常高,近一月多位分析师给出公司评级为买入。最高目标价2.00。中期看,股价处于平稳状态。近一个月,市场表现较差,但基本面评分较高。目前股价在压力位和支撑位之间,可以做区间波段操作。

cbdMD Inc评分

相关信息

行业排名
105 / 157
全市场排名
305 / 4565
所属行业
药品

压力支撑

由于公司未披露,未能获取相关数据

多维评测

本期评分
上期评分

公司舆情

过去24小时
热度

过冷
过热
看好

cbdMD Inc亮点

亮点风险
cbdMD, Inc. is a cannabidiol (CBD) company. The Company has a comprehensive line of United States produced, THC-free CBD products, including NSF Certified for Sport products, as well as its new Full Spectrum products. The Company's flagship brands include cbdMD and Paw CBD, as well as its functional mushroom brand ATRx Labs. Its cbdMD brand includes high-grade, premium CBD products including CBD tinctures, CBD gummies, CBD topicals, CBD capsules, CBD sleep aids and CBD drink products including its Herbal Oasis Social Tonic and an array of Farm Act compliant Delta 9 products. Its Paw CBD brand of pet products includes veterinarian-formulated products including tinctures, chews, topicals products in varying strengths, and its ATRx brand of natural functional mushroom support. Its cbdMD, Paw CBD and ATRx products are distributed through its e-commerce websites, third party e-commerce sites, select distributors and marketing partners as well as a variety of brick-and-mortar retailers.
业绩增长期
公司处于发展阶段,最新年度总收入19.19M美元
估值高估
公司最新PE估值0.02,处于3年历史高位

分析师目标

根据 1 位分析师
买入
评级
2.000
目标均价
+194.16%
涨幅空间

cbdMD Inc新闻

即将为您带来更多新闻,敬请期待。。。

财务指标

每股收益

由于公司未披露,未能获取相关数据

营业总收入

由于公司未披露,未能获取相关数据

cbdMD Inc简介

cbdMD, Inc. is a cannabidiol (CBD) company. The Company has a comprehensive line of United States produced, THC-free CBD products, including NSF Certified for Sport products, as well as its new Full Spectrum products. The Company's flagship brands include cbdMD and Paw CBD, as well as its functional mushroom brand ATRx Labs. Its cbdMD brand includes high-grade, premium CBD products including CBD tinctures, CBD gummies, CBD topicals, CBD capsules, CBD sleep aids and CBD drink products including its Herbal Oasis Social Tonic and an array of Farm Act compliant Delta 9 products. Its Paw CBD brand of pet products includes veterinarian-formulated products including tinctures, chews, topicals products in varying strengths, and its ATRx brand of natural functional mushroom support. Its cbdMD, Paw CBD and ATRx products are distributed through its e-commerce websites, third party e-commerce sites, select distributors and marketing partners as well as a variety of brick-and-mortar retailers.
公司代码YCBD
公司cbdMD Inc
CEOKennedy (T. Ronan)
网址https://www.cbdmd.com/

常见问题

cbdMD Inc(YCBD)的当前股价是多少?

cbdMD Inc(YCBD)的当前股价是 0.69。

cbdMD Inc的股票代码是什么?

cbdMD Inc的股票代码是YCBD。

cbdMD Inc股票的52周最高点是多少?

cbdMD Inc股票的52周最高点是2.56。

cbdMD Inc股票的52周最低点是多少?

cbdMD Inc股票的52周最低点是0.47。

cbdMD Inc的市值是多少?

cbdMD Inc的市值是7.19M。

现在cbdMD Inc(YCBD)的股票是买入、持有还是卖出?

根据分析师评级,cbdMD Inc(YCBD)的总体评级为买入,目标价格为2.00。

cbdMD Inc(YCBD)股票的每股收益(EPS TTM)是多少

cbdMD Inc(YCBD)股票的每股收益(EPS TTM)是-1.09。